Focuses on developments in the use of adeno-associated virus (AAV) serotypes. Definition of identified AAV serotypes derived from primates infected with wild-type adenovirus; Development of AAV to target defined organs and tissues; Results of the clinical trials for inherited disorders with advenovirus and AAV; Implications for gene therapy.